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steoblasts are derived from mesenchymal cells, and their number is determined by the rate of replication of precursors, their differentiation toward mature osteoblasts, and the death of mature cells (1) (2) (3) . Factors that govern these events determine the osteoblastic cell pool and play a substantial role in the formation of new bone (3) (4) (5) . Osteocytes are terminally differentiated osteoblasts that are embedded in the bone mineralized matrix in distinct lacunae (6, 7) . Osteocytes are dendritic cells that communicate through a canalicular network with each other and with osteoblasts and lining cells, which are also derived from osteoblasts. Osteocytes play a fundamental role in mechanotransduction, and osteocyte-ablated mice exhibit bone loss and microstructural deterioration (8) . Osteocytes and osteoblasts do not have redundant functions, and the impact of a regulatory signaling pathway may result in different outcomes when it operates in osteoblasts at various stages of cell differentiation or when it is activated in osteocytes.
Notch receptors (Notch 1 to 4) are single-pass transmembrane receptors that play a critical role in cell fate decisions (9 -12) . Notch regulates cell renewal in multiple organs and cell systems, and is involved in skeletal development and homeostasis, and in osteoblast differentiation (12) (13) (14) (15) . There are five Notch canonical ligands, which are Jagged1 and 2, and Delta Like1, 3, and 4 (9, 10, 12) . Notch-ligand interactions result in the proteolytic cleavage and release of the Notch intracellular domain (NICD), which translocates to the nucleus and interacts with C Promoter Binding factor 1, suppressor of hairless or Lag-1 (CSL), also termed Rbpj, and with mastermind-like proteins to regulate transcription (16 -19) . This is named the Notch canonical signaling pathway, which leads to the induction of hairy enhancer of split (Hes) and Hes related with YRPW motif (Hey) transcription factors (20) . Skeletal cells express Notch1 and Notch2 and low levels of Notch3 transcripts, but do not express detectable levels of Notch4 (21) (22) (23) . Notch1 and Notch2 appear to be responsible for the effects of Notch in the skeleton.
Previously, we have reported that the overexpression of Notch1 NICD in vitro inhibits osteoblast differentiation and that its overexpression in osteoblasts in vivo under the control of a 3.6 kilobase (kb) fragment of the Type I␣1 collagen (Col1a1) promoter causes osteopenia (15) . Studies performed by other investigators demonstrated that transgenic expression of Notch1 under the control of a 2.3-kb fragment of the Col1a1 promoter causes the formation of abundant woven bone, possibly because full osteoblastic maturity is not reached (13) . In accordance with the observations described, the conditional deletion of Notch1 and Notch2 in the developing skeleton causes a transient increase in bone volume and induces the commitment of mesenchymal precursor cells toward cells of the osteoblastic lineage (13, 14) .
Despite former observations indicating an inhibitory effect of Notch on osteoblastic differentiation, it is important to note that the biology of Notch is cell-context-dependent. The consequences of Notch activation on adult skeletal homeostasis in cells of the osteoblastic lineage at early stages of differentiation and in osteocytes have not been defined. It was our hypothesis that Notch would cause cell differentiation-dependent skeletal phenotypes. The intent of the present study was to define the function of Notch in vivo in cells of the osteoblastic lineage at various stages of differentiation and in osteocytes. For this purpose, we used the Rosa Notch mouse model, where a STOP cassette, placed between the Rosa26 promoter and the Notch1 NICD coding sequence, is flanked by loxP sites (24, 25) . Rosa Notch mice were crossed with transgenics expressing the Cre recombinase under the control of the Osterix (Osx), the Osteocalcin (Oc), the 2.3 kb fragment of Col1a1 (Col2.3), or the Dentin matrix protein1 (Dmp1) promoter (26 -30) . These four models should result in the preferential expression of the NICD by undifferentiated cells of the osteoblastic lineage (Osx), differentiated osteoblasts (Oc), osteocytes (Dmp1), or osteoblasts and osteocytes (Col2.3) (27, (31) (32) (33) (34) (35) . The skeletal phenotype of these four mouse models was established by microcomputed tomography (CT) and histomorphometry, and we explored possible mechanisms involved.
Materials and Methods

Rosa
Notch conditional mice Rosa Notch mice were created by D. A. Melton (Harvard University, Cambridge, Massachusetts) and obtained from Jackson Laboratory (Bar Harbor, Maine) in a 129SvJ/C57BL/6 genetic background (24, 25) . In these mice, the Rosa26 locus is targeted with a DNA construct encoding Notch1 NICD, preceded by a STOP cassette flanked by loxP sites, cloned downstream of the Rosa26 promoter. Expression of NICD from the targeted Rosa26 locus occurs following the excision of the STOP cassette by Cre recombination of loxP sequences (36, 37 (28) . Because the expression of Cre is under the control of the tet-off cassette, Rosa Notch moms were treated with 625 mg/kg of doxycycline from the time of conception to delivery. To study the induction of Notch in mature osteoblasts, homozygous Rosa Notch mice were bred with heterozygous transgenic mice expressing Cre under the control of the OSTEOCALCIN promoter (Oc-Cre), in a C57BL/6 genetic background obtained from T. Clemens (Baltimore, Maryland) (29, 30) . To study the induction of Notch in mature osteoblasts and osteocytes, we bred homozygous Rosa Notch mice with heterozygous transgenics expressing Cre under the control of the 2.3-kb fragment of the Col1a1 promoter (Col2.3-Cre) in a tropism to friend leukemia virus type B (FVB) background created by the laboratory of G. Karsenty and obtained from Mutated Mouse Regional Resource Center (Davis, California) (26) . To study the induction of Notch in osteocytes, we mated homozygous Rosa Notch mice with mice expressing Cre under the control of the Dmp1 promoter (Dmp1-Cre) in a C57BL/6 genetic background (27) Table 1A published on The Endocrine Society's Journals Online web site at http://endo.endojournals.org). Deletion of the loxP flanked STOP cassette by the Cre recombinase was documented by PCR in DNA from dissected tibiae devoid of bone marrow of 1-month-old Rosa Notch male mice using specific primers (Supplemental Table 1A ). The induction of Notch in the skeleton was confirmed by documenting NICD and Notch target gene mRNA expression in calvarial extracts by real time reverse transcription (RT)-PCR. All animal experiments were approved by the Animal Care and Use Committee of Saint Francis Hospital and Medical Center.
Microcomputed tomography (CT)
Bone microarchitecture of vertebrae and femurs from experimental and control mice was determined using a microcomputed tomographic instrument (CT 40; Scanco Medical AG, Bassersdorf, Switzerland) calibrated weekly using a phantom provided by the manufacturer (38, 39) . The vertebral body of L3 and femurs were scanned in 70% ethanol at high resolution, energy level of 55 kVp, intensity of 145 A, and integration time of 200 ms. Trabecular bone volume fraction and microarchitecture were evaluated starting approximately 1.0 mm from the cranial side of the vertebral body, or 1.0 mm proximal from the femoral condyles. For L3 and femurs, a total of 100 and 160 consecutive slices, respectively, were acquired at an isotropic voxel size of 6 m 3 and a slice thickness of 6 m, and chosen for analysis. Contours were manually drawn every 10 slices a few voxels away from the endocortical boundary to define the region of interest for analysis. The remaining slice contours were iterated automatically. Trabecular regions were assessed for total volume, bone volume, bone volume fraction (bone volume/total volume), trabecular thickness, trabecular number, trabecular separation, connectivity density, and structural model index using a Gaussian filter ( ϭ 0.8, support ϭ 1) and user-defined thresholds (38, 39) . For analysis of femoral cortical bone, contours were iterated across 100 slices along the cortical shell of the femoral midshaft, excluding the marrow cavity. Analysis of cortical thickness, bone volume/total volume, porosity, periosteal perimeter, endosteal perimeter, and material density were performed using a Gaussian filter ( ϭ 0.8. support ϭ 1) and userdefined thresholds. Femoral images acquired with CT were used to determine femoral length.
Bone histomorphometric analysis
Static and dynamic histomorphometry was carried out on experimental and control mice after they were injected with calcein, 20 mg/kg, and demeclocycline, 50 mg/kg, at an interval of 2 d for 1-month-old animals and 7 d for 3-month-old animals.
Col2.3-Cre;Rosa
Notch female mice were not injected with either calcein or demeclocycline because they appeared frail and early lethality was noted. Mice were sacrificed by CO 2 inhalation 2 d after the demeclocycline injection. Longitudinal sections of femurs, 5 m thick, were cut on a microtome (Microm, RichardsAllan Scientific, Kalamazoo, Michigan) and stained with 0.1% toluidine blue or von Kossa. Static parameters of bone formation and resorption were measured in a defined area between 360 m and 2160 m from the growth plate, using an OsteoMeasure morphometry system (Osteometrics, Atlanta, Georgia) (40) . For dynamic histomorphometry, mineralizing surface per bone surface and mineral apposition rate were measured on unstained sections under ultraviolet light, using a triple diamidino-2-phenylindole fluorescein texas red set long pass filter, and bone formation rate was calculated. The terminology and units used are those recommended by the Histomorphometry Nomenclature Committee of the American Society of Bone and Mineral Research (40) .
Real-time RT-PCR
Total RNA was extracted from calvariae or from femurs following the removal of the bone marrow by centrifugation, and mRNA levels determined by real-time RT-PCR (41, 42) . For this purpose, RNA was reverse-transcribed using iScript RT-PCR kit (BioRad, Hercules, California), according to manufacturer's instructions, and amplified in the presence of specific primers (Supplemental Table 1B ) and iQ SYBR Green SuperMix (BioRad) at 60°C for 45 cycles. Transcript copy number was estimated by comparison with a standard curve constructed using Notch1 (Thermo Scientific, Rockford, IL), Hey1, Hey2 (both from T. Iso, Los Angeles, CA), or HeyL (from D. Srivastava, Dallas, Texas) (43, 44) . Reactions were conducted in a CFX96 RT-PCR detection system (Bio-Rad), and fluorescence was monitored during every PCR cycle at the annealing step (43) . Data were pooled from male and female mice and are expressed as copy number corrected for glyceraldehyde-3-phosphate dehydrogenase (Gapdh), which was estimated by comparison to a standard curve constructed with Gapdh cDNA (from R. Wu, Ithaca, New York) (45) . Control values were normalized to 1.0.
Serum osteoprotegerin (OPG)
Levels of mouse Opg were measured by enzyme-linked immuno-absorbent assay in serum from 1-month-old male control and experimental mice according to manufacturer's instructions (R and D Systems, Minneapolis, Minnesota).
Statistical analysis
Data are expressed as means Ϯ SEM. Statistical differences were determined by unpaired Student's t test. Notch , and Dmp1-Cre; Rosa Notch mice were increased 1.5 to 4 fold (NICD and Hey1), 3-to 20-fold (Hey2) and 9-to 60-fold (HeyL) when compared with control Rosa Notch littermates, confirming induction of Notch signaling in the skeleton of the four models studied ( Figure 1 ). Notch activation was verified in femoral bone extracts, where Hey2 mRNA levels were increased (n ϭ 4) 3-to 16- Figure 2 ). Trabecular volume/tissue volume was decreased by 55% due to a decrease in trabecular thickness, and connectivity was reduced by 67%. Structural model index revealed that trabeculae were more rod-like than in control littermates. Cortical bone was modestly affected, and cortical porosity was increased by 2.4-fold in relationship to control littermates. Femoral histomorphometric analysis confirmed the osteopenic phenotype of Osx-Cre;Rosa Notch mice, and both trabecular thickness and number were decreased (Table 2, Figure 3 ). Although osteoblast number was increased, mineralizing surface and bone formation rate were decreased, explaining the phenotype observed and confirming that under the influence of Notch, osteoblasts fail to achieve full maturation or functional capacity so that the surface forming bone was decreased (12) . Osteoclast number and eroded surface were not different from controls in Osx-Cre;Rosa Notch mice. Accordingly, serum Opg levels were not affected and were (means Ϯ SEM; n ϭ 4 to 6) 529 Ϯ 34 ng/L in control male mice and 583 Ϯ 20 ng/L in Osx-Cre;Rosa Notch male littermates. Notch expression in mature osteoblasts (Oc-Cre;Rosa Notch ) also caused osteopenia. CT revealed a 55% decrease in trabecular volume/tissue volume due to a decrease in the thickness of trabeculae, which were more rod-like than in control mice (Table 1, Figure 2 ). Cortical bone was not present. Histomorphometric analysis confirmed that the osteopenia did not reveal a change in osteoblast cell number, and fluorescence microscopy revealed disorganized calcein and demeclocycline labels so that quantitative dynamic histomorphometric analysis could not be performed (Table 2, Figure 3 ). This labeling pattern suggests abnormal bone formation and dysfunctional osteoblasts. Osteoclast number and eroded surface were modestly reduced in female but not in male Oc-Cre;Rosa Notch mice, and serum Opg levels were reduced in Oc-Cre;Rosa Notch male mice from (means Ϯ SEM; n ϭ 3 to 4) 562 Ϯ 59 ng/L in control to 458 Ϯ 16 ng/L in Oc-Cre;Rosa Notch male littermates (P Ͻ .05).
Results
General characteristics of
In contrast to the osteopenic phenotype observed when Notch was expressed in immature and mature osteoblasts, the phenotype of mice expressing the NICD in osteoblasts and osteocytes (Col2. Figure 2 ). Cortical bone was not present. Histomorphometric analysis confirmed the phenotype and revealed a significant decrease in osteoclast number and eroded surface (Table 2, Figure 3 ). In accordance, serum Opg levels were increased from (means Ϯ SEM; n ϭ 4 to 6) 434 Ϯ 28 ng/L in control mice to 827 Ϯ 113 ng/L in Col2.3-Cre;Rosa Notch male littermates (P Ͻ .05). Dmp1-Cre;Rosa Notch mice exhibited a 3-to 3.2-fold increase in trabecular bone volume/ tissue volume due to an increase in trabecular number and had a pronounced increase in connectivity (4-to 10-fold) when compared with control mice. Cortical bone volume was increased by 3-fold, but cortical bone had the appearance of trabecular bone and a compact cortex was not observed, so that the cortical bone was porous (Table 1, Figure 2 ). Histomorphometric analysis confirmed the increase in trabecular bone volume, and revealed decreased osteoclast number and eroded surface (Table 2, Figure 3) . Mineral apposition rate, mineralizing surface, and bone formation rate were decreased, indicating suppressed bone remodeling. The histological appearance and number of osteocytes was not appreciably different in Dmp1-Cre;Rosa Notch mice when compared with controls. In accordance with the phenotype observed, serum Opg levels were increased from (means Ϯ SEM; n ϭ 6) 529 Ϯ 17 ng/L in control mice to 698 Ϯ 28 ng/L in Dmp1-Cre;Rosa Notch male littermates (P Ͻ .05). Figure 2) . Surprisingly, Col2.3-Cre;Rosa Notch mice exhibited vertebral osteopenia so that at femoral sites they phenocopied the osteocytic phenotype of Dmp1-Cre;Rosa Notch mice, whereas at vertebral sites they manifested the osteoblastic phenotype of Oc-Cre;Rosa Notch mice. (Table 4) . Femoral histomorphometry confirmed the increased bone volume secondary to an increased trabecular number. The number of osteoblasts was increased, but calcein-demeclocycline labeling revealed diffuse and fragmented labels in male mice, suggesting that the function of osteoblasts was not normal (Table  5 ). Dynamic histomorphometry in female mice revealed decreased bone formation. Osteoclast number was decreased in female Osx-Cre;Rosa Notch mice. Dmp1-Cre;Rosa Notch mice at 3 months of age exhibited a sustained increase in femoral trabecular bone volume and increased connectivity, but cortical bone could not be discerned from trabecular bone and the femur had the general appearance of osteosclerosis (Table 4) . Vertebral CT confirmed the femoral phenotype, and Dmp1-Cre;Rosa Notch mice exhibited an increase in vertebral cancellous bone volume due to an increase in trabecular number; connectivity density was increased by ϳ9-fold. In contrast to the results obtained at 1 month of age, femoral histomorphometry of Dmp1-Cre;Rosa Notch mice revealed increased bone resorption, although this was observed only in male mice (Table 5) . Bone formation could not be quantified because calcein-demeclocycline labels were diffuse and fragmented.
Vertebral microarchitecture of
Trabecular separation (m) 239 Ϯ 14 286 Ϯ 20 261 Ϯ 7 277 Ϯ 24 169 Ϯ 3 128 Ϯ 7 a 257 Ϯ 9 8 9 Ϯ 5 a Trabecular number (1/mm) 4.4 Ϯ 0.3 3.7 Ϯ 0.2 3.9 Ϯ 0.1 3.8 Ϯ 0.2 5.8 Ϯ 0.1 8.2 Ϯ 0.4 a 3.9 Ϯ 012 Ϯ 2 5 5 Ϯ 2 a Cortical thickness (m) 106 Ϯ 3 127 Ϯ 9 a 99 Ϯ 4 422 Ϯ 11 a Periosteal perimeter (mm) 4.3 Ϯ 0.1 4.3 Ϯ 0.1 4.4 Ϯ 0.1 5.1 Ϯ 0.1 a Endosteal perimeter (mm) 3.6 Ϯ 0.1 3.5 Ϯ 0.1 3.8 Ϯ 0.1 2.5 Ϯ
Discussion
Our findings demonstrate that Notch expression in cells of the osteoblastic lineage causes a cell-context-dependent skeletal phenotype. The conditional activation of Notch in the skeletal environment was achieved by expressing the Cre recombinase under the control of the Osx, Oc, Col2.3, or Dmp1 promoter, for the removal of a STOP cassette flanked by loxP sites upstream the Notch1 NICD. This resulted in Notch activation prenatally (Col2.3-Cre and Oc-Cre) and throughout the life of the animals studied so that the phenotype observed was in part due to effects on bone development, growth, and modeling (46 -48) . Osx is expressed at early stages of development in the mouse (embryonic day 13). Therefore, to ensure newborn viability, we prevented prenatal activation of Notch in Osx-Cre;Rosa Notch mice by treating pregnant moms with doxycycline, as Cre transcription was under the control of a tet-off cassette (28, 34) . Dmp1 is mostly expressed postnatally so that a prenatal phenotype was not expected (49) Notch mice, indicating suppressed bone remodeling. Although marked increases in bone volume are often found in response to increased bone formation, they also occur in conditions in which suppressed bone resorption and decreased remodeling are the dominant events, such as the inactivation of the receptor activator of nuclear factor-B (RANK) and the transgenic overexpression of Opg (50 -54) . For instance, the transgenic overexpression of Opg causes a 2-fold increase in bone volume secondary to a greater number of bone trabeculae in the context of a 90% suppression of bone formation (53) . The greater number of trabeculae probably represents preservation of previously formed bone, which failed to remodel. The phenotype of Dmp1-Cre;Rosa Notch mice is analogous to the one reported in Opg transgenics, and may be explained by an increase in serum levels of Opg.
The phenotype of the Col2.3-Cre;Rosa Notch mouse model is compatible with the one previously reported in transgenics expressing NICD under the control of the Col2.3 promoter, which was characterized by increased bone mass and osteosclerosis (13) . Osteoblast number was increased in Col2.3-NICD transgenics, although osteoblast function appeared to be impaired since immature woven bone was formed. A similar increase in osteoblast number with suppressed bone formation was observed in Osx-Cre;Rosa Notch mice, also indicative that the osteo- blasts formed were dysfunctional. In agreement with our findings, a reduced number of osteoclasts was noted in Col2.3-NICD transgenics and increased osteoclastogenesis, bone resorption, and osteopenia were reported in Notch loss of function mouse models by the same authors (13) . In contrast to the phenotype observed with gain of Notch function under the control of the 2.3-kb fragment of the type I collagen promoter, we reported that transgenics expressing the NICD under the control of a 3.6-kb fragment of the same promoter were osteopenic and exhibited early lethality (15) . The phenotype was secondary to a decrease in osteoblast number and presumably bone formation. The differences in the phenotypes observed can be explained by the differential activation of the 2.3-kb and 3.6-kb fragments of the type I collagen promoter resulting in the arrest of osteoblastic cell differentiation at different stages of maturation (55) . It is also possible that phenotypic differences in the two models reported are due to the greater and less restricted activity of the 3.6 kb than the 2.3-kb fragment of the type I collagen promoter to direct gene expression in cells of the osteoblastic lineage (48, 56) . An inhibitory role of Notch in osteoblastogenesis was also reported following the inactivation of Notch1 and 2 in the limb bud, although the predominant effect in this model was on mesenchymal progenitor cell differentiation and chondrogenesis (14, 57 has confirmed a rapid turnover of osteoblasts in vivo, and that a selected number of these cells differentiate into osteocytes (61) . Furthermore, osterix-expressing cells are not only a source of osteoblasts but also of osteocytes in vivo, supporting the notion that selected cells expressing Notch under the control of the Osx promoter eventually matured and became embedded in the bone matrix as osteocytes. The phenotype of Dmp1-Cre;Rosa Notch mice at 3 months of age revealed continued increase in bone volume although there was a tendency toward increased and not decreased bone remodeling. The studies presented document a unique phenotype characterized by markedly increased bone mass in mouse models of Notch gain of function in osteocytes, which are terminally differentiated osteoblasts embedded in the bone matrix (7) . A central function of osteocytes is to sense mechanical signals and transduce these into biological signals that regulate skeletal cell function (7) . Recently, we demonstrated that mechanical stimulation of the MLOY4 osteocytic cell line using fluid flow shear stress induces Notch signaling (E. Canalis, unpublished observations), leading to the hypothesis that Notch regulates mechanotransduction in osteocytes in addition to its distinct and previously unrecognized functional role in these cells.
The suppression of bone resorption by Notch is in accordance with the previously reported inhibitory effect of Notch on osteoclastogenesis. Notch inhibits osteoclast function by direct effects on osteoclast precursors and indirectly through its effects on cells of the osteoblastic lineage (14, 21) . Inactivation of Notch in osteoclast precursors causes increased osteoclastogenesis, and its inactivation in osteoblasts causes a modest increase in the expression of RANK ligand and a profound decrease in the expression of Opg, and as a consequence increased osteoclastogenesis (14, 21) . In accordance with these observations, we report increased serum levels of Opg and have also detected increased expression of Opg mRNA in calvarial extracts from Dmp1-Cre;Rosa Notch mice (E. Canalis, unpublished observations). The pronounced inhibition of bone resorption in mice expressing Notch preferentially in osteocytes is in accordance with the recently discovered function of osteocytes in bone remodeling and bone resorption (62) (63) (64) . A limitation of the present work is that the Cre recombinase used to activate Notch signaling was under the control of promoters that overlap in their expression pattern in cells of the osteoblastic lineage. Whereas Osteocalcin and Col2.3 are preferentially expressed by osteoblasts, their expression is not restricted to these cells and is also observed in osteocytes (47, 61, 65) . Similarly, Dmp1 is preferentially, but not exclusively, expressed by osteocytes (65) . As a consequence, preferential but not cell-specific Notch activation was responsible for the phenotypes reported.
In conclusion, activation of Notch in cells of the osteoblastic lineage causes effects that are dependent on the stage of cell maturation. Notch expression in immature and mature osteoblasts impairs osteoblast cell differentiation and causes osteopenia, whereas Notch expression in osteocytes causes an initial suppression of bone resorption and an increase in trabecular bone mass.
